Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II results for the DENVax vaccine reported at the ASTMH meeting

Nov. 25, 2013

DM-1992 shows promising plasma concentration-time profiles in phase II trials

Nov. 22, 2013

Preclinical combinatorial kinase inhibition of genetic mutation-based cancer growth

Nov. 22, 2013

AstraZeneca presents a potent, novel progesterone receptor antagonist

Nov. 22, 2013

MPO inhibitor PF-1355 demonstrates significant attenuation of cardiovascular and renal disorders

Nov. 22, 2013

DSR-85955 as a new mineralocorticoid receptor antagonist

Nov. 22, 2013

Phase II results for CSL-112 as a potential treatment for atherothrombotic disease

Nov. 22, 2013

Kyowa Hakko Kirin identifies lead compound for colon cancer

Nov. 21, 2013

DS-3078 evaluated in first-in-human advanced solid tumors study

Nov. 21, 2013

F-star generates an Fcab antibody against HER2

Nov. 21, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...